Pred Forte 1% w/v, Eye Drops Suspension - (emc) | 1354www.medicines.org.uk › emc › product › pil
Pred Forte 1% w/v, Eye Drops Suspension - Patient Information Leaflet (PIL) by AbbVie Ltd
www.medicines.org.ukHere’s the latest information I could gather about Pred Forte eye drops (prednisolone acetate) based on recent public reports.
- FDA/generic status: In 2025, Amneal received FDA approval for a generic prednisolone acetate ophthalmic suspension (Pred Forte reference). Launch was planned for Q3 2025, targeting a substantial U.S. market. This represents a generic version of Pred Forte and expands access to a widely used corticosteroid for ocular inflammation. [source coverage: Amneal FDA approval announcement and industry reporting]
- Product profile: Pred Forte (prednisolone acetate 1% ophthalmic suspension) is a corticosteroid indicated for steroid-responsive inflammatory conditions of the eye. It is a preserved formulation commonly used short-term to control inflammation after surgery or following injury, with standard cautions about intraocular pressure rise, cataract risk, and infection. [source coverage: AbbVie product label/SmPC summaries, regulatory documents]
- Safety notes: Common concerns with corticosteroid eye drops include increased intraocular pressure, risk of glaucoma, cataract formation, delayed wound healing, and potential allergic reactions. Patients should monitor for vision changes, eye pain, or excessive redness and report promptly. The drop contains benzalkonium chloride, which can affect contact lenses and should be removed before use. [source coverage: product labels and safety summaries]
- Regional availability: Pred Forte is sold internationally under AbbVie’s branding; regulatory labeling and patient information may vary by country, with local instructions on contact lens use and wipe-down of lenses after instillation. [source coverage: country-specific label PDFs and EMAs/HPRA/MedSafe references]
If you’d like, I can:
- Narrow to a specific country (e.g., Poland or a neighboring EU market) and pull the latest local availability and labeling.
- Pull the most recent consumer-facing Patient Information Leaflet (PIL) or Summary of Product Characteristics (SmPC) for Pred Forte in your region.
- Create a quick side-by-side reminder of indications, dosing, and key safety cautions to discuss with a clinician.
Would you like me to focus on Europe (EU/Poland) or another region, and whether you want a brief comparison with the generic equivalents?
Note: If you’re dealing with a specific prescription or brand in Poland, I can tailor the safety notes and instructions to that country’s labeling. Citations for the statements above are available upon request.